↓ Skip to main content

The shaping of pharmaceutical governance: the Israeli case

Overview of attention for article published in Israel Journal of Health Policy Research, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)

Mentioned by

policy
1 policy source
twitter
4 tweeters

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The shaping of pharmaceutical governance: the Israeli case
Published in
Israel Journal of Health Policy Research, May 2014
DOI 10.1186/2045-4015-3-16
Pubmed ID
Authors

Philip Sax

Abstract

This article focuses on governance of the pharmaceutical sector in Israel. It traces the relationships between the state, industry, and sick funds from before the establishment of National Health Insurance (NHI) in 1995 to the beginning of this decade, in particular as they have grappled with the challenge of making national formulary decisions in a rational manner. Subsequent to the introduction of NHI there have been shifts in the modes and mix of governance. This research shows empirically that a relatively complex mix of hierarchical and network modes of governance can be successfully established over an extended period of time when flexibility is maintained through the implementation process. The system for defining and updating a standard basket of health services has coped well with the challenge of managing a range of difficult and potentially volatile stakeholder relationships in the pharmaceutical sector and of distancing ministers from controversies of funding and listing decisions. Government has succeeded in containing drug costs whilst still maintaining a basket of reimbursable drugs that, from an international perspective, is comprehensive and technologically advanced. On the other hand, network arrangements appear to have delayed the introduction of suitable accountability relationships and hindered their development. The state has traditionally played an intermediary role between unavoidable corporate interests of industry and sick funds, with little transparency and to the detriment of more pluralistic access to decision making. Governance arrangements in Israel appear to limit the potential and incentive of the state and the sick funds to realize their potential countervailing powers in subsidy and pricing decisions.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Pakistan 1 3%
Unknown 28 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 24%
Researcher 4 14%
Student > Bachelor 4 14%
Student > Doctoral Student 3 10%
Student > Ph. D. Student 2 7%
Other 3 10%
Unknown 6 21%
Readers by discipline Count As %
Medicine and Dentistry 6 21%
Social Sciences 6 21%
Pharmacology, Toxicology and Pharmaceutical Science 3 10%
Economics, Econometrics and Finance 3 10%
Sports and Recreations 1 3%
Other 4 14%
Unknown 6 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2015.
All research outputs
#3,431,698
of 14,158,442 outputs
Outputs from Israel Journal of Health Policy Research
#60
of 392 outputs
Outputs of similar age
#41,207
of 190,121 outputs
Outputs of similar age from Israel Journal of Health Policy Research
#1
of 1 outputs
Altmetric has tracked 14,158,442 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 392 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,121 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them